Marketing-authorisation holder · Canada
Arcutis Canada, Inc.
4 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
4 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ZORYVE0.3 % / w/w · Cream | Roflumilast | Canada | Marketed | 2023 |
| ZORYVE0.3 % / w/w · Foam | Roflumilast | Canada | Marketed | 2024 |
| ZORYVE0.15 % / w/w · Cream | Roflumilast | Canada | Marketed | 2025 |
| ZORYVE0.05 % / w/w · Cream | Roflumilast | Canada | Marketed | 2026 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Canada | 4 | 4 | 0 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.